Senti Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -18.8% | -0.9% | +0.4% | -101.8% | – | -36.5% | +59.4% | -113.6% | – | -52.7% | -3.1% | – | |
| – | +404.6% | -39.1% | -161.7% | – | -9.4% | +99.0% | +26.7% | +1.6% | -8.1% | -7.7% | -20.3% | – | |
| – | – | -98.2% | +2,141.7% | +88.1% | -132.0% | – | – | – | -97.0% | +551.4% | -324.2% | – | |
| – | -99.8% | +275.0% | -100.0% | – | – | -100.0% | – | -100.0% | – | – | – | – | |
| – | -99.5% | -114.9% | – | – | -118.3% | – | – | -93.5% | – | +850.0% | – | – | |
| – | – | +0.0% | – | – | -200.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -200.0% | – | – | – | – | – | – | – | |
| – | – | +0.0% | -100.0% | – | +2,002.0% | -100.8% | – | -87.7% | +8,803.2% | -101.1% | – | – | |
| – | -211.1% | – | – | – | – | -138.3% | – | – | – | -279.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.